As shown in Figure 2G,H, the icaritin treatment effectively inhibited the MPTP-induced increases in IL-1β and TNF-α serum levels, indicating that icaritin reduced neuroinflammation in this model of PD. The gene discussed is TNF; the disease is Parkinson disease.